Simplex Trading
ACXP icon

Simplex Trading’s Acurx Pharmaceuticals ACXP Stock Holding History

Simplex Trading’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25
Closed -$1K – 8344
2024
Q2 		$1K Sell
25
-45
-64% -$1.98K ﹤0.01% 8404
2024
Q1 		$3K Sell
70
-385
-85% -$25K ﹤0.01% 8201
2023
Q4 		$34K Buy
+455
New +$34.3K ﹤0.01% 6443
2022
Q4 		– Sell
-25
Closed -$1K – 9066
2022
Q3 		$1K Buy
+25
New +$1.87K ﹤0.01% 9469

Other funds holding ACXP

PFS
Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return
GWSG
GPS Wealth Strategies Group Centennial, Colorado $117M AUM 24.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Simplex Trading's ACXP Position: Q3 2025 in Review

Simplex Trading sold out of Acurx Pharmaceuticals (ACXP) in Q3 2025, closing a stake of 344 shares — an estimated $3K sold.

Simplex Trading first reported a position in ACXP in Q1 2024 and held it in 5 quarters. The position peaked at $26K in Q1 2024. 16 funds tracked by Wall St. Rank hold ACXP as of Q3 2025.

  • Simplex Trading reported no remaining Acurx Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 344 Acurx Pharmaceuticals shares in Q3 2025, an estimated $3K.
  • Simplex Trading first reported a position in Acurx Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • Simplex Trading's Acurx Pharmaceuticals position peaked at $26K in Q1 2024.
  • 16 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.